Is GeneDx Holdings Corp. overvalued?

GeneDx Holdings Corp. (WGS) — key valuation metrics and fundamentals.

No verdict

Price

$52.37

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$1.57B

Dividend yield

0.0%

Return on equity

-42.3%

Sector

Healthcare

Fair value compares WGS's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.

Related stocks